The global animal health and nutrition company, Novus International, is planning to expand the supply of its gut heath probiotic, Sporulin, to all major poultry producing countries around the world.
After focusing its commercial efforts with the product in the US since 2012, Novus has announced a Sporulin expansion into Brazil, with many more countries set to follow.
“We are committed to deliver probiotic products that provide demonstrable value to feed and animal producers”, said the company’s global executive manager for eubiotics, Dave Zacek.
“We are therefore expanding the global reach of Sporulin, which has the ability to be a valuable tool for producers to support gut health in commercial poultry operations.”
The product was originally developed by University of Arkansas scientists working in collaboration with Pacific Vet Group, a company now wholly owned by the Denmark-based company, Novozymes.
